Answers are grounded in this paper and cite their sources.
Simultaneous kidney and liver transplantation (SKLT) is the surgical treatment modality for combined liver and kidney failure. Although it is a challenging procedure, but has got the added advantage of a single procedure and common immunosuppression therapy. Recently, the practice of deceased donors SKLT has increased dramatically in the West. However, it is less frequently performed with living donors. Here, we describe a successful SKLT procedure from two separate living donors in a 31-year male, who presented with end-stage renal disease secondary to hypertensive nephropathy and decompensated chronic liver disease secondary to hepatitis C infection. The patient had a smooth recovery and on 1-year follow-up, he is stable.
No takes yet. Share an insight, caveat, or question.
A 2022 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: